ClinicalTrials.gg
CompletedNCT07702344Updated Oct 7, 2026

Circadian Rhythm and Health in Heavy Industry Shift Workers

An observational study in Shift Work Disorder and Shift Work Type Circadian Rhythm Sleep Disorder, sponsored by Istanbul Gedik University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-10-07.

Sponsored by Istanbul Gedik University · Observational

How we know

Updated Oct 7, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
226
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 60 studies in Musculoskeletal Pain with a site in Turkey — 13 open to participants now, 15 under way, none of them phase 3. Musculoskeletal Pain · Turkey.

Enrollment
7th of 30
226 · median 146
Started
2026
with 16 others
Observational
30 of 60
7 open now
Registered
54th of 60
by date

Among the 60 studies in Musculoskeletal Pain with a site in Turkey, this one is the 7th largest by enrollment of the 30 observational ones that give a count, is one of 17 that started in 2026, is one of 30 observational ones, and was the 54th registered.

Musculoskeletal Pain

518 studies on the registry are indexed under Musculoskeletal Pain; 127 are open to participants now.

Browse Musculoskeletal Pain studies →

Open to participants now

13 of the 60 studies in Musculoskeletal Pain with a site in Turkey are open now. Recruiting first, the newest first:

8 more — sign in →

All 13 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 66 Musculoskeletal Pain studies recruiting now, 30 (45%) set no upper age limit and 30 (45%) stop at 75 or younger; 8 take children under 18; 18 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 60 studies in Musculoskeletal Pain with a site in Turkey, or all of them as a file.
02

Study summary

Shift work can disrupt the body's circadian rhythm, which may negatively affect sleep, musculoskeletal health, and quality of life. Heavy industry workers who perform rotating or night shifts may be particularly vulnerable to these health problems. This cross-sectional observational study will evaluate circadian rhythm characteristics, musculoskeletal pain, sleep quality, and quality of life among heavy industry shift workers. Participants will complete validated questionnaires assessing chronotype, musculoskeletal symptoms, sleep quality, and quality of life. The study will examine the associations between chronotype and these health outcomes and compare the results across different chronotype groups. The findings may contribute to a better understanding of the health effects of shift work and support the development of occupational health strategies for shift workers

03

Conditions studied

  • Shift Work Disorder
  • Shift Work Type Circadian Rhythm Sleep Disorder

Browse trials for

Keywords

  • Shift Work
  • Circadian Rhythm
  • Chronotype
  • Musculoskeletal pain
  • Sleeep quality
  • Quality of life
  • occupational health
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Shift workers: Heavy industry workers employed in a shift work system will be recruited from participating industrial workplaces in İstanbul, Kocaeli in Türkiye. Eligible participants will be adults aged 18 to 65 years who have been working in a rotating or night shift schedule for at least 3 months and are willing to participate in the study.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Ages 18-65
  • Working in a shift system for at least 3 months
  • Agreeing to participate in the work voluntarily
  • Being a shift worker

Exclusion criteria

Exclusion Criteria:

  • Presence of using any medication that may affect alertness or muscle activity
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
226 participants (actual)
Patient registry
No

Groups and cohorts

  • Heavy Industry Shift Workers

    Heavy industry workers who perform shift work and will undergo a single questionnaire-based assessment.

    Other: Questionnaire-Based Assessment

Interventions

  • OtherQuestionnaire-Based Assessment

    Participants will complete validated self-administered questionnaires to assess chronotype, musculoskeletal pain, sleep quality, and quality of life. No therapeutic intervention will be administered.

06

What researchers measure

Primary outcomes

  1. Morningness-Eveningness Questionnaire (MEQ)

    The Morningness-Eveningness Questionnaire (MEQ) is a validated 19-item self-administered questionnaire used to determine an individual's chronotype (morning, intermediate, or evening type). Total scores range from 16 to 86. Higher scores indicate a greater preference for morningness, whereas lower scores indicate a greater preference for eveningness.

    Time frame: At enrollment (single assessment)

Secondary outcomes

  1. Cornell Musculoskeletal Discomfort Questionnaire (CMDQ)

    The Cornell Musculoskeletal Discomfort Questionnaire (CMDQ) is a validated self-administered questionnaire used to assess the frequency, severity, and work-related impact of musculoskeletal discomfort in different body regions. The total score is calculated by summing weighted scores across body regions and does not have a fixed minimum or maximum value. Higher scores indicate greater musculoskeletal discomfort.

    Time frame: At enrollment (single assessment)

  2. Pittsburgh Sleep Quality Index (PSQI)

    The Pittsburgh Sleep Quality Index (PSQI) is a validated self-administered questionnaire used to evaluate sleep quality over the previous month. Total scores range from 0 to 21, with higher scores indicating poorer sleep quality.

    Time frame: At enrollment (single assessment)

  3. World Health Organization Quality of Life-BREF (WHOQOL-BREF)

    The World Health Organization Quality of Life-BREF (WHOQOL-BREF) is a validated self-administered questionnaire that assesses quality of life across the physical, psychological, social, and environmental domains. Domain scores are transformed to a 0-100 scale, with higher scores indicating better quality of life.

    Time frame: At enrollment (single assessment)

07

Study locations

1 site
  • Istanbul Gedik University
    Istanbul, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Ran from Jul 2026 to primary completion in Oct 2026, 2 months.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 7, 2026: primary completion Sep 2026 → Oct 2026 and completion Sep 2026 → Oct 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 9, 2026
First posted
Jul 14, 2026
StartActual
Jul 20, 2026
Primary completionActual
Oct 5, 2026was Sep 2026
CompletionActual
Oct 5, 2026was Sep 2026
Last update
Oct 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Oct 7, 2026
Primary completion
Sep 20, 2026→Oct 5, 2026 (actual)
Oct 7, 2026
Study completion
Sep 30, 2026→Oct 5, 2026 (actual)
Oct 7, 2026
Enrollment
220 (estimated)→226 (actual)
Oct 7, 2026
Show all 1 update
  1. Oct 7, 2026
    Recruiting→Completed
    Primary completion Sep 20, 2026→Oct 5, 2026 (now actual)
    Study completion Sep 30, 2026→Oct 5, 2026 (now actual)
    Enrollment 220 (estimated)→226 (actual)
    + 2 other changes: contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07702344
Lead sponsor
Istanbul Gedik University
Responsible party
Amine Ataç (Asst. Prof., Istanbul Gedik University) — Principal investigator
First posted
Jul 14, 2026
Start date
Jul 20, 2026
Primary completion
Oct 5, 2026
Completion
Oct 5, 2026
Last update
Oct 7, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion